Literature DB >> 27376954

Phenotyping GABA transaminase deficiency: a case description and literature review.

Pedro Louro1, Lina Ramos2, Conceição Robalo2, Cândida Cancelinha2, Alexandra Dinis2, Ricardo Veiga2, Raquel Pina2, Olinda Rebelo2, Ana Pop3, Luísa Diogo2, Gajja S Salomons3, Paula Garcia2.   

Abstract

Gamma-aminobutyric acid transaminase (GABA-T) deficiency is an autosomal recessive disorder reported in only three unrelated families. It is caused by mutations in the ABAT gene, which encodes 4-aminobutyrate transaminase, an enzyme of GABA catabolism and mitochondrial nucleoside salvage. We report the case of a boy, deceased at 12 months of age, with early-onset epileptic encephalopathy, severe psychomotor retardation, hypotonia, lower-limb hyporeflexia, central hypoventilation, and rapid increase in weight and, to a lesser rate, length and head circumference. He presented signs of premature pubarche, thermal instability, and water-electrolyte imbalance. Serum total testosterone was elevated (43.3 ng/dl; normal range <16), as well as serum growth hormone (7.7 ng/ml; normal range <1). Brain magnetic resonance imaging (MRI) showed decreased myelination and generalized brain atrophy, later confirmed by post-mortem examination. ABAT gene sequencing was performed post-mortem, identifying a homozygous variant c.888G > T (p.Gln296His),not previously described. In vitro analysis concluded that this variant is pathogenic. The clinical features of this patient are similar to those reported so far in GABA-T deficiency. However, distinct mutations may have a different effect on enzymatic activity, which potentially could lead to a variable clinical outcome. Clinical investigation aiming for a diagnosis should not end with the patient's death, as it may allow a more precise genetic counselling for the family.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27376954     DOI: 10.1007/s10545-016-9951-z

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  6 in total

Review 1.  GABA-based evaluation of neurologic conditions: MR spectroscopy.

Authors:  L M Levy; A J Degnan
Journal:  AJNR Am J Neuroradiol       Date:  2012-01-19       Impact factor: 3.825

Review 2.  Review: Normal and abnormal central nervous system GABA metabolism in childhood.

Authors:  J Jaeken; P Casaer; K D Haegele; P J Schechter
Journal:  J Inherit Metab Dis       Date:  1990       Impact factor: 4.982

3.  Occurrence of GABA and GABA receptors in human spermatozoa.

Authors:  M N Ritta; J C Calamera; D E Bas
Journal:  Mol Hum Reprod       Date:  1998-08       Impact factor: 4.025

4.  Gamma-aminobutyric acid-transaminase deficiency: a newly recognized inborn error of neurotransmitter metabolism.

Authors:  J Jaeken; P Casaer; P de Cock; L Corbeel; R Eeckels; E Eggermont; P J Schechter; J M Brucher
Journal:  Neuropediatrics       Date:  1984-08       Impact factor: 1.947

5.  The GABA transaminase, ABAT, is essential for mitochondrial nucleoside metabolism.

Authors:  Arnaud Besse; Ping Wu; Francesco Bruni; Taraka Donti; Brett H Graham; William J Craigen; Robert McFarland; Paolo Moretti; Seema Lalani; Kenneth L Scott; Robert W Taylor; Penelope E Bonnen
Journal:  Cell Metab       Date:  2015-03-03       Impact factor: 27.287

6.  A new case of GABA transaminase deficiency facilitated by proton MR spectroscopy.

Authors:  Megumi Tsuji; Noriko Aida; Takayuki Obata; Moyoko Tomiyasu; Noritaka Furuya; Kenji Kurosawa; Abdellatif Errami; K Michael Gibson; Gajja S Salomons; Cornelis Jakobs; Hitoshi Osaka
Journal:  J Inherit Metab Dis       Date:  2010-01-06       Impact factor: 4.982

  6 in total
  3 in total

Review 1.  Phenotype of GABA-transaminase deficiency.

Authors:  Mary Kay Koenig; Ryan Hodgeman; James J Riviello; Wendy Chung; Jennifer Bain; Claudia A Chiriboga; Kazushi Ichikawa; Hitoshi Osaka; Megumi Tsuji; K Michael Gibson; Penelope E Bonnen; Phillip L Pearl
Journal:  Neurology       Date:  2017-04-14       Impact factor: 9.910

2.  2-Pyrrolidinone and Succinimide as Clinical Screening Biomarkers for GABA-Transaminase Deficiency: Anti-seizure Medications Impact Accurate Diagnosis.

Authors:  Adam D Kennedy; Kirk L Pappan; Taraka Donti; Mauricio R Delgado; Marwan Shinawi; Toni S Pearson; Seema R Lalani; William E Craigen; V Reid Sutton; Anne M Evans; Qin Sun; Lisa T Emrick; Sarah H Elsea
Journal:  Front Neurosci       Date:  2019-05-08       Impact factor: 4.677

3.  CRISPR/Cas9-engineered Gad1 elimination in rats leads to complex behavioral changes: implications for schizophrenia.

Authors:  Kazuyuki Fujihara; Kazuo Yamada; Yukio Ichitani; Toshikazu Kakizaki; Weiru Jiang; Shigeo Miyata; Takashi Suto; Daiki Kato; Shigeru Saito; Masahiko Watanabe; Yuki Kajita; Tomokazu Ohshiro; Hajime Mushiake; Yoshiki Miyasaka; Tomoji Mashimo; Hiroki Yasuda; Yuchio Yanagawa
Journal:  Transl Psychiatry       Date:  2020-12-08       Impact factor: 6.222

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.